4//SEC Filing
Webb Michael J. 4
Accession 0001209191-11-059146
CIK 0001333170other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:31 PM ET
Size
9.1 KB
Accession
0001209191-11-059146
Insider Transaction Report
Form 4
Webb Michael J.
SVP, Quality & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2011-12-01$4.54/sh+10,000$45,400→ 27,390 total - Exercise/Conversion
Stock Option (Right to Buy)
2011-12-01−10,000→ 32,000 totalExercise: $4.54From: 2008-04-27Exp: 2015-03-26→ Common Stock (10,000 underlying) - Sale
Common Stock
2011-12-01$19.71/sh−10,000$197,136→ 17,390 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 19, 2011.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.54 to $19.82. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F3]This option was granted on March 27, 2008 and vests over four years in equal monthly installments.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001409195
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:31 PM ET
- Size
- 9.1 KB